Submission Details
| 510(k) Number | K011780 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 07, 2001 |
| Decision Date | July 25, 2001 |
| Days to Decision | 48 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
K011780 is an FDA 510(k) clearance for the K-ASSAY C1-INA, a Complement C1 Inhibitor (inactivator), Antigen, Antiserum, Control (Class II — Special Controls, product code DBA), submitted by Kamiya Biomedical Co. (Seattle, US). The FDA issued a Cleared decision on July 25, 2001, 48 days after receiving the submission on June 7, 2001. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5250.
| 510(k) Number | K011780 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 07, 2001 |
| Decision Date | July 25, 2001 |
| Days to Decision | 48 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
| Product Code | DBA — Complement C1 Inhibitor (inactivator), Antigen, Antiserum, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5250 |